TC Home

The only technical publication dedicated to readers who formulate, manufacture, or package solid dosage forms.

Slide background
Slide background
  • March 6, 2021

SILVER SPRING, MD—The FDA approved Lupkynis (voclosporin) in combination with a background immunosuppressive therapy regimen to treat adult patients with active lupus nephritis. This is the first FDA-approved oral drug for the treatment of this condition. The product is manufactured by Aurinia Pharmaceuticals, Victoria, BC.